Omega-3 Fatty Acids (DHA/EPA) für Cerebrovascular Health

Q: Does Omega-3 Fatty Acids (DHA/EPA) help with Cerebrovascular Health?

Based on 12 studies with 2,000 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (DHA/EPA) may support Cerebrovascular Health management. Our evidence grade is B (Good Evidence).

Q: How much Omega-3 Fatty Acids (DHA/EPA) should I take for Cerebrovascular Health?

Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?

Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Cerebrovascular Health?

We rate the evidence as Grade B (Good Evidence). This rating is based on 12 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

DHA supports vascular endothelial function and may help reduce neuroinflammation. In CAD patients, 3.36 g/day supplementation was associated with slowed cognitive aging equivalent to approximately 2.5 years.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dcerebrovascular\u002Dhealth'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Fazit

Key Study Findings

Review

The Clinical Implications of Ashwagandha (Withania somnifera L.) with a Special Reference to Side Effects-A …

Dose: None vs.: None Outcome: None Wirkung: None None

Population: narrative review of ashwagandha clinical trials and basic research (1994-present)

Other 10 weeks

Ginkgo biloba Extract GBE50 ameliorates cerebrovascular dysfunction and cognitive impairment in a mouse model of …

Dose: None vs.: Untreated APP/PS1 mice Outcome: Cognitive performance in behavioral tests Wirkung: None None

Population: APP/PS1 transgenic Alzheimer's disease mouse model

Review

Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage Guidelines.

Dose: None vs.: None Outcome: ASD symptom management Wirkung: None None

Population: Children with autism spectrum disorder

Cohort Study n=215624

Neuroticism, omega-3 fatty acids, and risk of incident dementia.

Dose: None vs.: None Outcome: Incident all-cause dementia Wirkung: None <0.05 (Bonferroni)

Population: Dementia-free UK Biobank participants aged 40-69

preclinical animal/in vitro study

Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice …

Dose: 60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL vs.: Placebo Wirkung: None None

Other 26 weeks

Systems biology modelling based evaluation of omega-3 formulation in managing cardiovascular and cerebrovascular risk.

Dose: EPA 180mg + DHA 120mg vs.: Simulated disease population baseline Outcome: Lipid biomarker changes (in silico model) Wirkung: 14.7% TG reduction, 22.38% HDL increase None

Population: Simulated CVD disease population (in silico study)

Key Statistics

Studien

2000

Teilnehmer

↑

Positive

Bewertung

Referenced Papers

The Clinical Implications of Ashwagandha (Withania somnifera L.) with a Special Reference to Side Effects-A Review. Review

Nutrients 2026

Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice by enhancing the brain-derived neurotrophic … Other

Journal of ethnopharmacology 2025 9 Zitierungen

Natural sulfur compounds in mental health and neurological disorders: insights from observational and intervention studies. Review

Frontiers in nutrition 2025 7 Zitierungen

Ginkgo biloba Extract GBE50 ameliorates cerebrovascular dysfunction and cognitive impairment in a mouse model of Alzheimer's disease. Other

Phytomedicine : international … 2025 6 Zitierungen

Coenzyme Q10 and Cognition: A Review. Review

Nutrients 2025 2 Zitierungen

Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage Guidelines. Review

Alternative therapies in … 2025

Systems biology modelling based evaluation of omega-3 formulation in managing cardiovascular and cerebrovascular risk. Other

Scientific reports 2025

Neuroticism, omega-3 fatty acids, and risk of incident dementia. Other

Journal of affective … 2025

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. Review

Degenerative neurological and … 2024 66 Zitierungen

[Not Available]. Review

Acta pharmaceutica Sinica. … 2024 33 Zitierungen

Effects of vitamins and polyunsaturated fatty acids on cognitive function in older adults with mild cognitive impairment: a meta-analysis of … Meta-Analysis

European journal of … 2024 16 Zitierungen

Oxytocin and Vasopressin Gene Expression in the Brain as Potential Biomarkers for Cannabidiol Therapeutic Efficacy. Other

Biomedicines 2024 3 Zitierungen

[Pharmacotherapies for insomnia]. Other

La Revue du … 2024

Lipids at the Nexus between Cerebrovascular Disease and Vascular Dementia: The Impact of HDL-Cholesterol and Ceramides. Review

International journal of … 2023 23 Zitierungen

trans-2-Enoyl-CoA Reductase Tecr-Driven Lipid Metabolism in Endothelial Cells Protects against Transcytosis to Maintain Blood-Brain Barrier Homeostasis. Other

Research (Washington, D.C.) 2022 38 Zitierungen

Glucosinolates and Omega-3 Fatty Acids from Mustard Seeds: Phytochemistry and Pharmacology. Review

Plants (Basel, Switzerland) 2022 26 Zitierungen

Hydroalcoholic Extract of Ashwagandha Improves Sleep by Modulating GABA/Histamine Receptors and EEG Slow-Wave Pattern in In Vitro - In Vivo … Other

Preventive nutrition and … 2022 18 Zitierungen

Inulin Supplementation Mitigates Gut Dysbiosis and Brain Impairment Induced by Mild Traumatic Brain Injury during Chronic Phase. Other

Journal of cellular … 2022 15 Zitierungen

Revisiting brain iron deficiency in restless legs syndrome using magnetic resonance imaging. Meta-Analysis

NeuroImage. Clinical 2022 14 Zitierungen

A Novel Combination of High-Load Omega-3 Lysine Complex (AvailOm®) and Anthocyanins Exerts Beneficial Cardiovascular Effects. Other

Antioxidants (Basel, Switzerland) 2022 10 Zitierungen

Prolonging effects of Valeriana fauriei root extract on pentobarbital-induced sleep in caffeine-induced insomnia model mice and the pharmacokinetics of its … Other

Journal of ethnopharmacology 2022 8 Zitierungen

Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial. Other

BMJ open 2022 3 Zitierungen

Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events". Other

Clinical nutrition (Edinburgh, … 2022 1 Zitierungen

Restless legs syndrome. Review

Nature reviews. Disease … 2021 163 Zitierungen

Ashwagandha (Withania somnifera) root extract attenuates hepatic and cognitive deficits in thioacetamide-induced rat model of hepatic encephalopathy via induction of … Other

Journal of ethnopharmacology 2021 69 Zitierungen

DHA intake relates to better cerebrovascular and neurodegeneration neuroimaging phenotypes in middle-aged adults at increased genetic risk of Alzheimer disease. Other

The American journal … 2021 25 Zitierungen

The Clinical Efficacy of Ginkgo biloba Leaf Preparation on Ischemic Stroke: A Systematic Review and Meta-Analysis. Review

Evidence-based complementary and … 2021 24 Zitierungen

Fish consumption, long-chain omega-3 fatty acids intake and risk of stroke: An updated systematic review and meta-analysis. Meta-Analysis

Asia Pacific journal … 2021 16 Zitierungen

Characterization of pharmaco-EEG fingerprint and sleep-wake profiles of Lavandula angustifolia Mill. essential oil inhalation and diazepam administration in rats. Other

Journal of ethnopharmacology 2021 16 Zitierungen

Online Promotion of "Brain Health" Supplements. Other

The Senior care … 2021 2 Zitierungen

Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial. RCT

EBioMedicine 2020 107 Zitierungen

Neurodegenerative diseases and Withania somnifera (L.): An update. Review

Journal of ethnopharmacology 2020 85 Zitierungen

Evaluation of Cognitive Performance following Fish-Oil and Curcumin Supplementation in Middle-Aged and Older Adults with Overweight or Obesity. RCT

The Journal of … 2020 33 Zitierungen

Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. Systematic Review

Journal of integrative … 2020 33 Zitierungen

The Veterans Administration and Department of Defense clinical practice guidelines for the diagnosis and management of sleep disorders: what does … Other

Journal of clinical … 2020 17 Zitierungen

Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Review

South African medical … 2020 5 Zitierungen

[Similarities and differences between Ginkgo biloba and Panax notoginseng in treatment of ischemic cerebrovascular disease]. Other

Zhongguo Zhong yao … 2020 3 Zitierungen

Mediterranean diet: The role of long-chain ω-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and … Review

Revue neurologique 2019 361 Zitierungen

Multiple Health Benefits and Minimal Risks Associated with Vegetarian Diets. Review

Current nutrition reports 2019 68 Zitierungen

L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial. RCT

Journal of psychiatric … 2019 46 Zitierungen

Sleep Disorders in Wilson's Disease. Review

Current neurology and … 2019 11 Zitierungen

Effects of Omega-3 Fatty Acids on Resting Cerebral Perfusion in Patients with Mild Cognitive Impairment: A Randomized Controlled Trial. RCT

The journal of … 2018 24 Zitierungen

Glycerophospholipid Supplementation as a Potential Intervention for Supporting Cerebral Structure in Older Adults. Other

Frontiers in aging … 2018 23 Zitierungen

Brain imaging and networks in restless legs syndrome. Review

Sleep medicine 2017 95 Zitierungen

Are Dietary Supplements and Nutraceuticals Effective for Musculoskeletal Health and Cognitive Function? A Scoping Review. Review

The journal of … 2017 75 Zitierungen

Treatment of Sleep Dysfunction in Parkinson's Disease. Review

Current treatment options … 2017 56 Zitierungen

Review of Safety and Efficacy of Sleep Medicines in Older Adults. Review

Clinical therapeutics 2016 328 Zitierungen

DHA Supplementation Alone or in Combination with Other Nutrients Does not Modulate Cerebral Hemodynamics or Cognitive Function in Healthy Older … RCT

Nutrients 2016 53 Zitierungen

Associations of dietary polychlorinated biphenyls and long-chain omega-3 fatty acids with stroke risk. Other

Environment international 2016 24 Zitierungen

Concurrent Use of Low-Dose Aspirin and Omega-3 Fatty Acids and Risk of Upper Gastrointestinal Complications: A Cohort Study with Nested … Other

Basic & clinical … 2016 5 Zitierungen

Zinc-containing yeast extract promotes nonrapid eye movement sleep in mice. Other

Molecular nutrition & … 2015 18 Zitierungen

The Beyond Ageing Project Phase 2--a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an … RCT

Trials 2015 17 Zitierungen

Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease. Other

Neurobiology of aging 2014 73 Zitierungen

Baseline plasma fatty acids profile and incident cardiovascular events in the SU.FOL.OM3 trial: the evidence revisited. RCT

PloS one 2014 22 Zitierungen

[The effects of Omega-3 fatty acids in clinical medicine]. Review

Praxis 2014 1 Zitierungen

[Atrial fibrillation after coronary artery bypass surgery: possibilities of prevention]. Review

Srpski arhiv za … 2012 3 Zitierungen

Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. Review

Journal of clinical … 2011 396 Zitierungen

Alternative drug therapies for dementia. Other

Journal of psychosocial … 2011 26 Zitierungen

OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted … RCT

Circulation 2010 593 Zitierungen

Can nutrients prevent or delay onset of Alzheimer's disease? Review

Journal of Alzheimer's … 2010 110 Zitierungen

Normal cognitive decline or dementia? Other

The Practitioner 2010

The potential role of nutritional components in the management of Alzheimer's Disease. Review

European journal of … 2008 49 Zitierungen

Therapeutic options for sleep-maintenance and sleep-onset insomnia. Review

Pharmacotherapy 2007 117 Zitierungen

Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans. Review

Brain research reviews 2007 102 Zitierungen

The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Other

Anesthesia and analgesia 2004 127 Zitierungen

Differences in diabetic co-morbidity between Aboriginal and non-Aboriginal people living in Bella Coola, Canada. Other

Rural and remote … 2004 14 Zitierungen

Folic acid with or without vitamin B12 for cognition and dementia. Systematic Review

The Cochrane database … 2003 263 Zitierungen

Pharmacologic treatments of dementia. Review

The Medical clinics … 2002 59 Zitierungen

Actions of Ginkgo Biloba related to potential utility for the treatment of conditions involving cerebral hypoxia. Review

Life sciences 2000 41 Zitierungen

Influence of diethyl maleate and cysteine on tissue glutathione and growth in broiler chickens. Other

Poultry science 1995 16 Zitierungen

Dietary omega-3 fatty acids and endothelium-dependent responses in porcine cerebral arteries. Other

Stroke 1992 25 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:: 1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:: 1,000-1,700 mg/day (optimal dose-response curve)

Obergrenze: 3,000 mg/day combined DHA/EPA (FDA GRAS)

In der Forschung untersuchte Dosierungen

Dosierung	Dauer	Wirkung	N
None	--	Positive	--
None	10 weeks	Positive	--
None	--	Positive	--
None	--	Positive	215624
60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL	--	Positive	--
EPA 180mg + DHA 120mg	26 weeks	Positive	--
None	--	Mixed	--
None	--	Mixed	--

Beste Einnahmezeit: With meals containing fat for better absorption

Safety & Side Effects

Gemeldete Nebenwirkungen

⚠ Fishy aftertaste or burping
⚠ Mild gastrointestinal discomfort
⚠ Potential increased bleeding time at very high doses
⚠ May lower blood pressure slightly

Bekannte Wechselwirkungen

● Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
● Blood pressure medications (additive hypotensive effect)
● Orlistat (may reduce omega-3 absorption)

Tolerierbare Höchstaufnahmemenge: 3,000 mg/day combined DHA/EPA (FDA GRAS)

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with Cerebrovascular Health?

Based on 12 studies with 2,000 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (DHA/EPA) may support Cerebrovascular Health management. Our evidence grade is B (Good Evidence).

How much Omega-3 Fatty Acids (DHA/EPA) should I take for Cerebrovascular Health?

Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?

Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Cerebrovascular Health?

We rate the evidence as Grade B (Good Evidence). This rating is based on 12 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

Andere Inhaltsstoffe für Cerebrovascular Health

Ginkgo biloba B Resveratrol C

Omega-3 Fatty Acids (DHA/EPA) für andere Beschwerden

Age-Related Cognitive Decline A Mild Cognitive Impairment (MCI) B Depression-Related Cognitive Dysfunction B Attention & Focus Difficulties C

Kurzfazit

Evidence Strength72%

High confidence

Studienübersicht

RCT (8)Meta (3)Other (1)

Alternativen vergleichen

Sehen Sie, wie andere Inhaltsstoffe bei dieser Beschwerde abschneiden.

Alle Inhaltsstoffe ansehen für Cerebrovascular Health

Mehr erfahren

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.